Lorlatinib can cause visual and auditory hallucinations. And, it is necessary to keep in mind that hallucinations can persist even after discontinuation in patients who develop hallucinations while receiving lorlatinib.
Keywords: Japanese patient; hallucinations; lorlatinib; nonsmall‐cell lung cancer.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.